在严重喘中使用特塞佩卢马布的有效性:一个多中心的真实世界研究
Remo Poto1, Gianluca Manganello2, Antonio di Salvatore3
1Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy; Istituti Clinici Scientifici Maugeri-IRCCS Scientific Institute of Telese Terme, Benevento, Italy.
European journal of internal medicine
|September 27, 2025
概括
泰塞佩卢马布 (Tezepelumab) 是一种胸膜 stromal lymphopoietin (TSLP) 阻断剂,在现实环境中有效改善了严重喘控制. 这种生物药物对肺功能有显著的益处,并减少了各种患者表型的口服类固醇使用.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘仍然是一个重大的治疗挑战,许多患者无法控制目前的生物药物,向2型 (T2) 炎症.
- 胸膜 stromal 淋巴蛋白 (TSLP) 是一种上游细胞因子,涉及喘病变,使其成为新型干预的目标.
- 针对TSLP的单克隆抗体Tezepelumab在临床试验中表现有前途,但需要现实世界的数据.
研究的目的:
- 评估tezepelumab在患有严重喘的患者中的实际有效性和安全性.
- 评估tzepelumab对控制喘,喘恶化,口服葡萄糖皮质激素使用和肺功能的影响.
- 探索不同炎症表型 (T2-高和T2-低) 的治疗效应.
主要方法:
- 一项前性,多中心的观察性研究,涉及30名严重喘患者,在最大的吸入治疗中控制不充分.
- 患者每4周接受tezepelumab 210毫克.
- 临床结果,肺功能和生物标志物的数据在基线和6个月治疗后收集.
主要成果:
- 在喘控制测试 (ACT) 得分中观察到显著改善,口服葡萄糖皮质醇使用和恶化率大幅降低.
- 肺功能,包括FEV1/FVC比率和FEF25-75,有所改善,这表明对空气流量限制和小气道功能有好处.
- 生物标志物,如血中乙酸氨基和分数呼出的氧化 (FeNO) 减少,而总IgE保持稳定;没有报告严重的不良事件.
结论:
- 在真实世界严重喘患者群体中,Tezepelumab显示出显著的临床有效性和有利的安全性.
- 在T2高和T2低的表型中观察到的好处表明TSLP阻断提供了广泛的治疗方法.
- 需要进一步的大规模,长期的研究来证实这些发现,并确定治疗反应的预测因素.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:24Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
692
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
692